EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multi-Attribute Monitoring Method for Process Development of Engineered Antibody for Site-Specific Conjugation

Alistair R Hines iD, Matthew Edgeworth, Paul W A Devine, Samuel Shepherd, Nicholas Chatterton, Claire Turner, Kathryn S Lilley iD, Xiaoyu Chen, Nicholas J Bond iD

Journal of the American Society for Mass Spectrometry · 2023

DOI: 10.1021/jasms.3c00037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Society for Mass Spectrometry, 2023. Verfasst von Alistair R Hines und 8 weiteren Autor:innen. Beteiligte Einrichtung: Analytical Sciences, Biopharmaceutical Development R&D, AstraZeneca, Cambridge, CB2 0AA, United Kingdom. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Immunoconjugates. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibody drug conjugates, a class of biotherapeutic proteins, have been extensively developed in recent years, resulting in new approvals and improved standard of care for cancer patients. Among the numerous strategies of conjugating cytotoxic payloads to monoclonal antibodies, insertion of a cysteine residue achieves a tightly controlled, site-specific drug to antibody ratio. Tailored analytical tools are required to direct the development of processes capable of manufacturing novel antibody scaffolds with the desired product quality. Here, we describe the development of a 12 min, mass-spectrometry-based method capable of monitoring four distinct quality attributes simultaneously: variations in the thiol state of the inserted cysteines, N-linked glycosylation, reduction of interchain disulfide bonds, and polypeptide fragmentation. This method provides new insight into the properties of the antibody intermediate and associated manufacturing processes. Oxidized thiol states are formed within the bioreactor, of which a variant containing an additional disulfide bond was produced and remained relatively constant throughout the fed-batch process; reduced thiol variants were introduced upon harvest. Nearly 20 percent of N-linked glycans contained sialic acid, substantially higher than anticipated for wildtype IgG1. Lastly, previously unreported polypeptide fragmentation sites were identified in the C239i constant domain, and the relationship between fragmentation and glycoform were explored. This work illustrates the utility of applying a high-throughput liquid chromatography-mass spectrometry multi-attribute monitoring method to support the development of engineered antibody scaffolds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalImmunoconjugatesHumansChromatography, LiquidCysteineSulfhydryl CompoundsDisulfides

Stichwörter der Autor:innen

antibody intermediateantibody-drug conjugate (ADC)biologic manufacturing processesglycosylationmass spectrometry (MS)multi-attribute monitoring (MAM)site-specific conjugation

Substanzen

Antibodies, MonoclonalImmunoconjugatesCysteineSulfhydryl CompoundsDisulfides

Autor:innen und Institutionen

  • Analytical Sciences, Biopharmaceutical Development R&D, AstraZeneca, Cambridge, CB2 0AA, United Kingdom.
  • School of Life, Health and Chemical Sciences, The Open University, Walton Hall, Milton Keynes, MK7 6AA, United Kingdom.
  • College of Health, Medicine & Life Sciences, Brunel University London, Middlesex, UB8 3PH, United Kingdom.
  • Cambridge Centre for Proteomics, Department of Biochemistry, University of Cambridge, Cambridge, CB2 1QR, United Kingdom.
  • Analytical Sciences, Biopharmaceutical Development, R&D, AstraZeneca, Gaithersburg, Maryland 20878, United States.

ORCID-Profile: Alistair R Hines, Kathryn S Lilley, Nicholas J Bond

Förderung

  • AstraZeneca

Zitieren

APA

Hines, A. R., Edgeworth, M., Devine, P. W. A., Shepherd, S., Chatterton, N., Turner, C., Lilley, K. S., Chen, X., & Bond, N. J. (2023). Multi-Attribute Monitoring Method for Process Development of Engineered Antibody for Site-Specific Conjugation. Journal of the American Society for Mass Spectrometry. https://doi.org/10.1021/jasms.3c00037

Vancouver

Hines AR, Edgeworth M, Devine PWA, Shepherd S, Chatterton N, Turner C, et al. Multi-Attribute Monitoring Method for Process Development of Engineered Antibody for Site-Specific Conjugation. Journal of the American Society for Mass Spectrometry. 2023. doi:10.1021/jasms.3c00037

BibTeX
@article{Hines2023,
  author = {Hines, Alistair R and Edgeworth, Matthew and Devine, Paul W A and Shepherd, Samuel and Chatterton, Nicholas and Turner, Claire and Lilley, Kathryn S and Chen, Xiaoyu and Bond, Nicholas J},
  title = {Multi-Attribute Monitoring Method for Process Development of Engineered Antibody for Site-Specific Conjugation},
  journal = {Journal of the American Society for Mass Spectrometry},
  year = {2023},
  doi = {10.1021/jasms.3c00037}
}
Kostenlos starten →